The BODE index after lung volume reduction surgery correlates with survival

Area of Science:

• Pulmonary Medicine
• Surgical Outcomes Research
• Cardiopulmonary Rehabilitation

Background:

• Chronic Obstructive Pulmonary Disease (COPD) poses significant mortality risks.
• Lung Volume Reduction Surgery (LVRS) is a treatment option for severe emphysema.
• Predictive indices are crucial for patient selection and prognosis after LVRS.

Purpose of the Study:

• To evaluate the BODE index's ability to predict survival in COPD patients undergoing LVRS.
• To compare the predictive power of the BODE index against individual components like FEV1 and dyspnea.

Main Methods:

• Retrospective analysis of 186 COPD patients undergoing bilateral thoracoscopic LVRS.
• Assessment of BODE index components (BMI, FEV1, dyspnea, 6MWD) pre- and post-surgery.
• Survival follow-up for a median of 40 months.

Main Results:

• The BODE index significantly decreased post-LVRS (7.2 to 4.0, p < 0.001).
• Postoperative BODE index strongly correlated with survival, unlike the preoperative index.
• A lower BODE score class post-surgery was associated with reduced mortality (HR 0.497).
• The BODE index demonstrated superior predictive ability (C-statistic 0.74) compared to FEV1 (0.63), dyspnea (0.64), or 6MWD (0.62).

Conclusions:

• The postoperative BODE index is a powerful and reliable predictor of survival in COPD patients after LVRS.
• The BODE index offers a more comprehensive prognostic assessment than individual clinical parameters.